In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 10, 2014, Pages 2207-2215

  Yang, Guang ^a,b   Yang, Tan ^a   Zhang, Wendian ^a   Lu, Miao ^a   Ma, Xiang ^a   Xiang, Guangya ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JIANGHAN UNIVERSITY   (China)

Author keywords

folate receptor (FR); KB tumor; liposome; targeting therapy; ursolic acid (UA)

Indexed keywords

BIOCHEMISTRY; CELL DEATH; LIPOSOMES; TUMORS; CARBOXYLIC ACIDS; MOBILE SECURITY;

ANTI-TUMOR EFFICACY; CELL CYCLE ANALYSIS; CELLULAR UPTAKE EFFICIENCY; ENTRAPMENT EFFICIENCY; FOLATE RECEPTOR; HUMAN EPIDERMOID CARCINOMA; TARGETING THERAPY; URSOLIC ACID; THIN FILM DISPERSION;

CARBOXYLIC ACIDS; DRUG PRODUCTS;

ANTINEOPLASTIC AGENT; CHOLESTEROL ESTER; CHOLESTEROL SUCCINATE; FOLATE RECEPTOR; FOLIC ACID; LIPOSOME; MACROGOL DERIVATIVE; TRITERPENE; URSOLIC ACID;

ANIMAL; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; BAGG ALBINO MOUSE; BIOAVAILABILITY; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; METABOLISM; METHODOLOGY; MOLECULARLY TARGETED THERAPY; MOUSE; MOUTH TUMOR; SOLUBILITY; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CARCINOMA, SQUAMOUS CELL; CHOLESTEROL ESTERS; DRUG DELIVERY SYSTEMS; FEMALE; FOLATE RECEPTORS, GPI-ANCHORED; FOLIC ACID; HUMANS; LIPOSOMES; MICE; MICE, INBRED BALB C; MOLECULAR TARGETED THERAPY; MOUTH NEOPLASMS; POLYETHYLENE GLYCOLS; SOLUBILITY; TRITERPENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84896384116     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf405675g     Document Type: Article

References (44)

1. Frighetto, R. T. S.; Welendorf, R. M.; Nigro, E. N.; Frighetto, N.; Siani, A. C. Isolation of ursolic acid from apple peels by high speed counter-current chromatography Food Chem. 2008, 106, 767-771
2. Kim, E.; Sy-Cordero, A.; Graf, T. N.; Brantley, S. J.; Paine, M. F.; Oberlies, N. H. Isolation and identification of intestinal CYP3A inhibitors from cranberry (Vaccinium macrocarpon) using human intestinal microsomes Planta Med. 2011, 77 (3) 265-270
3. Hsu, C.; Hong, B.; Yu, Y.; Yen, G. Antioxidant and anti-inflammatory effects of Orthosiphon aristatus and its bioactive compounds J. Agric. Food Chem. 2010, 58, 2150-2156
4. Abe, F.; Yamauchi, T.; Nagao, T.; Kinjo, J.; Okabe, H.; Higo, H.; Akahane, H. Ursolic acid as a trypanocidal constituent in rosemary Biol. Pharm. Bull. 2002, 25, 1485-1487
5. Liu, J. Oleanolic acid and ursolic acid: research perspectives J. Ethnopharmacol. 2005, 100, 92-94
6. Liu, X. S.; Jiang, J. Induction of apoptosis and regulation of the MAPK pathway by ursolic acid in human leukemia K562 cells Planta Med. 2007, 73 (11) 1192-1194
7. He, X.; Wang, Y.; Hu, H.; Zhang, Z. In vitro and in vivo antimammary tumor activities and mechanisms of the apple total triterpenoids J. Agric. Food Chem. 2012, 60, 9430-9436
8. Wang, J.; Ren, T. N.; Xi, T. Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells Med Oncol. 2012, 29, 10-15
9. Hsu, Y. L.; Kuo, P. L.; Lin, C. C. Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells Life Sci. 2004, 75 (19) 2303-2316
10. Manu, K. A.; Kuttan, G. Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells Int. Immunopharmacol. 2008, 8 (7) 974-981
11. Achiwa, Y.; Hasegawa, K.; Komiya, T.; Udagawa, Y. Ursolic acid induces Bax-dependent apoptosis through the caspase-3 pathway in endometrial cancer SNG-II cells Oncol. Rep. 2005, 13 (1) 51-57
12. Cuicu, Z.; Xishan, H. A phase I clinical trial of ursolic acid nanoliposome for evaluating its single-dose tolerance and safety Chinese J. New Drugs 2011, 20 (2) 148-151
13. Cerga, O.; Borcan, F. Syntheses of new cyclodextrin complexes with oleanolic and ursolic acids J. Agroaliment. Processes Technol. 2011, 17 (4) 405-409
14. Zhu, Z.; Qian, Z. A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors Int. J. Nanomed. 2013, 8, 129-136
15. Chen, C.; Han, D.; Cai, C.; Tang, X. An overview of liposome lyophilization and its future potential J. Controlled Release 2010, 142, 299-311
16. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discovery 2005, 4, 145-160
17. Mamot, C.; Drummond, D. C.; Hong, K.; Kirpotin, D. B.; Park, J. W. Liposome-based approaches to overcome anticancer drug resistance Drug Resist. Updates 2003, 6, 271-279
18. Immordino, M. L.; Dosio, F.; Cattel, L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomed. 2006, 1, 297-315
19. Li, S. D.; Huang, L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting J. Controlled Release 2010, 145, 178-181
20. Song, C. K.; Jung, S. H.; Kim, D. D.; Jeong, K. S.; Shin, B. C.; Seong, H. Disaccharide-modified liposomes and their in vitro intracellular uptake Int. J. Pharm. 2009, 380 (1-2) 161-169
21. Takara, K.; Hatakeyama, H.; Ohga, N.; Hida, K.; Harashima, H. Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake Int. J. Pharm. 2010, 396 (1-2) 143-148
22. Torchilin, V. P. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers Adv. Drug Delivery Rev. 2008, 60 (4-5) 548-558
23. Li, X.; Ding, L.; Xu, Y.; Wang, Y.; Ping, Q. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin Int. J. Pharm. 2009, 373 (1-2) 116-123
24. Ying, X.; Wen, H. E.; Lu, W. L. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Controlled Release 2010, 141 (2) 183-192
25. Hattori, Y.; Maitani, Y. Enhanced in vitro DNA Transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer J. Controlled Release 2004, 97, 173-183
26. Riviere, K.; Huang, Z.; Jerger, K. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration J. Drug Target. 2011, 19 (1) 14-24
27. Tyagi, N.; Ghosh, P. C. Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated into folate-tagged liposomes Eur. J. Pharm. Sci. 2011, 43 (4) 343-353
28. Pan, X. Q.; Lee, R. J. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model Anticancer Res. 2005, 25 (1A) 343-346
29. Xie, M.; Zhang, H.; Xu, Y.; Liu, T.; Chen, S.; Wang, J.; Zhang, T. Expression of folate receptors in nasopharyngeal and laryngeal carcinoma and folate receptor-mediated endocytosis by molecular targeted nanomedicine Int. J. Nanomed. 2013, 8, 2443-2451
30. Sega, E. I.; Low, P. S. Tumor detection using folate receptor-targeted imaging agents Cancer Metastasis Rev. 2008, 27, 655-664
31. Xiang, G.; Wu, J.; Lu, Y.; Liu, Z.; Lee, R. J. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes Int. J. Pharm. 2008, 356, 29-36
32. Dua, J. S.; Rana, A. C.; Bhandari, A. K. Liposome: methods of preparation and applications Int. J. Pharm. Stud. Res. 2012, 47, 14-20
33. Liu, J. B.; Lee, H. L.; Huesca, M.; Young, A. P.; Allen, C. Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy Cancer Chemother. Pharmacol. 2006, 58, 306-318
34. Hinrichs, W. L.; Mancěnido, F. A.; Sanders, N. N.; Braeckmans, K.; De Smedt, S. C.; Demeester, J.; Frijlink, H. W. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying Int. J. Pharm. 2006, 311, 237-244
35. Mohanty, C.; Sahoc, S. K. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as aqueous nanoparticulate formulation Biomaterials 2010, 31, 6597-6611
36. Pasut, G.; Canala, F.; Schiavon, O. Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid J. Controlled Release 2008, 127, 239-248
37. Heo, S. J.; Kim, K. N.; Yoon, W. J.; Oh, C.; Choi, Y. U.; Affan, A. Chromene induces apoptosis via caspase-3 activation in human leukemia HL-60 cells Food Chem. Toxicol. 2011, 49, 1998-2004
38. Lei, M.; Ni, J. In vitro study on the anti-proliferation and apoptosis of ursolic acid in human ACC-83 cells J. Oral Maxillofacial Surg. 2010, 20, 389-393
39. Lu, Y.; Wu, J.; Lee, R. J. Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells Mol. Pharmaceutics 2007, 4, 707-712
40. Gabizon, A.; Shmeeda, H.; Horowitz, A. T.; Zalipsky, S. Tumor cell targeting of liposome-entrapped drugs with phospholipids-anchored folic-PEG conjugates Adv. Drug Delivery Rev. 2004, 56, 1177-1192
41. Gabizon, A.; Shmeeda, H.; Zalipsky, S. Pros and cons of the liposome platform in cancer drug targeting J. Liposome Res. 2006, 16, 175-183
42. Soukaina Réjiba, L.; Reddy, H.; Hajri, A. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer Nanomedicine 2011, 7 (6) 841-849
43. Both, D. M.; Goodtzova, K.; Yarosh, D. B.; Brown, D. A. Liposome-encapsulated ursolic acid increases ceramides and collagen in human skin cells Arch. Dermatol. Res. 2002, 293, 569-575
44. Lee, R. J.; Low, P. S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro Biochim. Biophys. Acta 1995, 1233, 134-144